Connor, Clark & Lunn Investment Management Ltd.

Position in CCCC — C4 Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in CCCC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,404,427

+$675,436 QoQ

Shares Held

300,734

+8.5% QoQ

Ownership

0.244%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#49

of 147 holders

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names. CCCC ranks #56 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,404,427	300,734	+8.5%	Shares	Sole	2026-08-13
2026-03-31	$728,991	277,183	+634.8%	Shares	Sole	2026-05-11
2025-12-31	$72,047	37,721	-78.4%	Shares	Sole	2026-02-10
2024-03-31	$1,424,488	174,356	+3.6%	Shares	Sole	2024-05-09
2023-12-31	$950,431	168,218	+2.1%	Shares	Sole	2024-02-09
2023-09-30	$306,382	164,722	-5.5%	Shares	Sole	2023-11-13
2023-06-30	$479,487	174,359	+53.1%	Shares	Sole	2023-08-10
2023-03-31	$357,624	113,893	+687.8%	Shares	Sole	2023-05-10
2022-12-31	$85,296	14,457	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.